YARROW BIOSCIENCE, INC. Restructuring and Related Cost, Number of Positions Eliminated
YARROW BIOSCIENCE, INC. (YARW) reported Restructuring and Related Cost, Number of Positions Eliminated of 70 employee for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2023-03-14
- YARROW BIOSCIENCE, INC. restructuring and related cost, number of positions eliminated for fiscal 2022 was 70.00 employee.
| Period end | Restructuring and Related Cost, Number of Positions Eliminated 12 month | Restructuring and Related Cost, Number of Positions Eliminated 12 month as first filed |
|---|---|---|
| 2022-12-31 | 70.00 employee 10-K · filed 2023-03-14 | |
| 2021-12-31 | 28.00 employee 10-Q · filed 2022-11-14 | 70.00 employee 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |